Physician profile
Stephanie M Llop Quintana
NPI 1538422357
$2,202.03
in general payments reported to CMS, 2019-2025
7 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Uveitis and Ocular Inflammatory Disease provider received nationally (typical 2025 total: $471).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.40 · 2022: $1,620 · 2024: $369 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $1,620.00 | 2022 | |
| Alcon Vision LLC | $285.39 | 2024-2025 | Clareon, Centurion |
| Bausch & Lomb Americas INC. | $172.90 | 2024-2025 | Xipere, Scoutpro Osmolarity System |
| Genentech USA, INC. | $62.60 | 2024 | Vabysmo |
| Mallinckrodt Hospital Products INC. | $27.68 | 2025 | Acthar |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Alimera Sciences, INC. | $14.06 | 2024 | Iluvien, Yutiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Llop Quintana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.